510(k) Report

510(k) · Cleared

Cleared

Pro-B Biopsy Needle

K951598510(k) TraditionalCleared Apr 21, 199514-day reviewClass II21 CFR 876.1075

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Promedical, Ltd. · FCG Biopsy Needle

Cleared on Apr 21, 1995 after a 14-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 3 later devices descend from it.

Decided
Apr 21, 1995
Review
14 days
Class
Class II
Product code
FCG
Recalls
None
Predicates
0

3 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 1997: 1 descendant cleared1996: 1 descendant cleared2001: 1 descendant cleared1995200020052010201520202025
  1. This deviceK951598 Pro-B Biopsy NeedlePromedical, Ltd. · 1995
  2. Descendant · cites it directly · 0 of its ownK013069 BiospeedH.S. Hospital Services S.P.A. · 2001
  3. Descendant · cites it directly · 0 of its ownK964777 TZGallini Intl., Inc. · 1997
  4. Descendant · cites it directly · 0 of its ownK962905 TX Biopsy NeedleGallini S.R.L. · 1996

Most influential descendants

Showing 3 of 3 · See all
  • K013069BiospeedH.S. Hospital Services S.P.A. · 2001 · cites it directly0descendants
  • K964777TZGallini Intl., Inc. · 1997 · cites it directly0descendants
  • K962905TX Biopsy NeedleGallini S.R.L. · 1996 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K951598Pro-B Biopsy NeedlePromedical, Ltd.1995—
+1K013069BiospeedH.S. Hospital Services S.P.A.2001—
+1K964777TZGallini Intl., Inc.1997—
+1K962905TX Biopsy NeedleGallini S.R.L.1996—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199610
199710
200110
FIG. 1 — Lineage of K951598, 1995–2001Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FCG device

  1. #1 K250994 ClearTip FNA and FNB Typesscore 13.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K013069BiospeedH.S. Hospital Services S.P.A.20010
K964777TZGallini Intl., Inc.19970
K962905TX Biopsy NeedleGallini S.R.L.19960

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K013069 (H.S. Hospital Services S.P.A., 2001) has gone furthest, with 0 descendants of its own.

How does its category compare?

All FCG devices

FCG Biopsy Needle: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FCG

2in 2025

2007: 42008: 12009: 42010: 32011: 12013: 12014: 52015: 42016: 32017: 32018: 62020: 12021: 12022: 22023: 42024: 12025: 2
2007high 6 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FCG

82in 2023

2007: 32 days median2009: 87 days median2010: 18 days median2014: 88 days median2015: 91 days median2016: 63 days median2017: 166 days median2018: 140 days median2023: 82 days median
2007high 166 (2017) · low 18 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FCG

5in 2021

2008: 192009: 52010: 42011: 22021: 5
2007high 19 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FCG

632in 2025

2007: 112008: 1152009: 2702010: 732011: 712012: 1072013: 1302014: 1542015: 1242016: 1912017: 2732018: 2822019: 2292020: 2402021: 2902022: 3022023: 4282024: 4462025: 632
2007high 632 (2025) · low 11 (2007)2025

MAUDE reports naming product code FCG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007432011
20081—19115
20094875270
2010318473
20111—271
20120—0107
20131—0130
20145880154
20154910124
20163630191
201731660273
201861400282
20190—0229
20201—0240
20211—5290
20222—0302
20234820428
20241—0446
20252—0632
20260—0—
Cite this page

510(k) Report. “K951598: Pro-B Biopsy Needle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K951598

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026